Reversible Contraceptive Device Market Global Report 2026

The reversible contraceptive device market size has grown strongly in recent years. It will grow from $14.25 billion in 2025 to $15.6 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to rising awareness of family planning methods, increased availability of contraceptive services, expansion of women’s reproductive healthcare programs, improved access to healthcare facilities, and growing utilization of long-acting reversible contraception.

The reversible contraceptive device market size is expected to see strong growth in the next few years. It will grow to $22.56 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be linked to increasing demand for personalized contraceptive solutions, rising adoption of advanced implant-based technologies, growing investment in reproductive healthcare innovation, expanding access to contraceptive methods in emerging economies, and increasing preference for highly effective reversible birth control options. Key trends expected in the forecast period include greater adoption of long-acting reversible contraceptive devices, rising preference for hormone-releasing intrauterine systems, increasing demand for minimally invasive contraceptive solutions, expansion of self-administered contraceptive products, and stronger focus on enhancing comfort and user-friendly design features in contraceptive devices.

The rising participation of women in the workforce is expected to drive the growth of the reversible contraceptive device market going forward. Female workforce participation refers to the proportion of women of working age who are either employed or actively seeking employment in the labor market. The increase in female workforce participation is driven by improved access to education, as higher education levels enable more women to qualify for diverse job opportunities and enter the workforce. Reversible contraceptive devices support female workforce participation by allowing women to effectively plan and space pregnancies, thereby promoting career continuity, financial independence, and long-term employment opportunities. For instance, in 2025, according to the World Bank, a US-based government-backed data source, in Brazil, female labor force participation increased from 43.32% in 2023 to 43.34% in 2024. Therefore, the increasing female workforce participation is driving the growth of the reversible contraceptive device market.

Leading companies operating in the reversible contraceptive device market are focusing on developing advanced solutions, such as low-dose copper intrauterine systems, to improve user comfort, reduce side effects, and enhance contraceptive effectiveness. Low-dose copper intrauterine systems refer to next-generation devices that use a smaller amount of copper while maintaining high efficacy, thereby minimizing adverse effects such as heavy bleeding and discomfort. For example, in February 2025, Sebela Womens Health Inc., a US-based pharmaceutical company, received approval for MIUDELLA, a novel hormone-free copper intrauterine device designed for pregnancy prevention. The device features a flexible frame and reduced copper surface area, aiming to improve tolerability while maintaining long-term contraceptive protection.

In February 2026, Organon & Co., a US-based pharmaceutical company focused on women’s health, entered into a partnership with Sebela Pharmaceuticals Inc. for MIUDELLA, a hormone-free copper intrauterine device (IUD). Through this agreement, Organon expanded its reversible contraceptive device portfolio by strengthening its long-acting reversible contraception (LARC) offerings and improving access to non-hormonal contraceptive solutions. Sebela Pharmaceuticals Inc. is a US-based specialty pharmaceutical company engaged in women’s health products, contributing to the reversible contraceptive device market through the development of intrauterine contraceptive technologies.

Major companies operating in the reversible contraceptive device market are Bayer AG, Organon & Co., Merck & Co. Inc., Reckitt Benckiser Group plc, Church & Dwight Co. Inc., CooperCompanies Inc., Gedeon Richter Plc., HLL Lifecare Limited, DKT International, MSI Reproductive Choices, Medicines360, Pregna International Limited, Sebela Pharmaceuticals Inc., Shanghai Dahua Pharmaceutical Co. Ltd., SMB Corporation of India, Eurogine S.L., Veru Inc., Kessel medintim GmbH, OCON Medical Ltd., Daré Bioscience Inc., NEXT Life Sciences Inc., Gynocare Services Private Limited.

North America was the dominant region in the reversible contraceptive device market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in reversible contraceptive device report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the reversible contraceptive device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reversible contraceptive device market consists of sales of vaginal rings, transdermal contraceptive patches, injectable contraceptive devices, and barrier contraceptive devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The reversible contraceptive device market research report is one of a series of new reports that provides reversible contraceptive device market statistics, including reversible contraceptive device industry global market size, regional shares, competitors with a reversible contraceptive device market share, detailed reversible contraceptive device market segments, market trends and opportunities, and any further data you may need to thrive in the reversible contraceptive device industry. This reversible contraceptive device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.